Philip M. Young - 22 Jul 2025 Form 4 Insider Report for CARLSMED, INC.

Reporting relationship: Director
Issuer ticker: CARL on Nasdaq
Reported as of: 22 Jul 2025
Net transaction value: +$899,985
SEC form: 4
Accepted by SEC: 24 Jul 2025, 20:25:31 UTC
Next SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Leonard Greenstein, as attorney-in-fact for Philip Young

Key filing fact

Philip M. Young filed Form 4 for CARLSMED, INC. on 24 Jul 2025.

Key facts

This page summarizes Philip M. Young's Form 4 filing for CARLSMED, INC..
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jul 2025, 20:25.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$899,985.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001048637 Primary reporting owner

YOUNG PHILIP M

Relationship: Director
Address: C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD
Signature: /s/ Leonard Greenstein, as attorney-in-fact for Philip Young
Signature date: 24 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CARL transaction

Common Stock

Award

Transaction value: $0
Shares: +17,333
Change %
Price: $0.000000
Shares after: 17,333
Date: 22 Jul 2025
Ownership: Direct
Footnotes: F1, F2

CARL transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +28,900
Change %
Price
Shares after: 28,900
Date: 24 Jul 2025
Ownership: See Footnotes
Footnotes: F3, F4, F5

CARL transaction

Common Stock

Purchase

Transaction value: $99,990
Shares: +6,666
Change %: +23%
Price: $15.00
Shares after: 35,566
Date: 24 Jul 2025
Ownership: See Footnotes
Footnotes: F4, F5, F6, F7

CARL transaction

Common Stock

Purchase

Transaction value: $799,995
Shares: +53,333
Change %
Price: $15.00
Shares after: 53,333
Date: 24 Jul 2025
Ownership: See Footnotes
Footnotes: F8, F9, F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CARL transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares: -28,900
Change %: -100%
Price
Shares after: 0
Date: 24 Jul 2025
Ownership: See Footnotes
Underlying class: Common Stock
Underlying amount: 28,900
Exercise price
Footnotes: F3, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Constitute an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years.

Footnote F2

Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock.

Footnote F3

These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.

Footnote F4

Stock held by PMY Partners LP.

Footnote F5

Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.

Footnote F6

Includes 6,666 shares of the Issuer's common stock purchased by PMY Partners L.P. in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.

Footnote F7

(7) Includes (i) 6,666 shares of the Issuer's common stock purchased by PMY Partners L.P. in the Issuer's initial public offering at the public offering price of $15.00 per share, and (ii) 28,900 shares of common stock issued to PMY Partners L.P. upon the conversion of outstanding preferred stock on a 1-to-1 basis, immediately prior to the closing of the Issuer's public offering.

Footnote F8

Includes 53,333 shares of the Issuer's common stock purchased by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees (the "Trust") in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.

Footnote F9

Stock held by the Trust.

Footnote F10

Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.